// App-Quantinova.ai

: Transcriptomic heterogeneity of androgen receptor activity in primary prostate cancer: Identification and characterization of a low AR-active subclass.

Researchers

Presenter

  • Daniel Eidelberg Spratt

Principal Investigators

  • Mohammed Alshalalfa

  • Adam Weiner

  • Nick Fishbane

  • Rohit Mehra

  • Rayford Walter

  • Nicholas Erho

  • Adam Dicker

  • Stephen J. Freedland

  • Jeffrey Karnes

  • Andrew Glass

  • Sheila Weinmann

  • Elai Davicioni

  • Ashley Ross

  • Robert Benjamin Den

  • Felix Y Feng

  • Edward M. Schaeffer

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • GenomeDx Biosciences Inc., Vancouver, BC, Canada

  • Northwestern University, Chicago, IL

  • University of Michigan, Ann Arbor, MI

  • Baptist Memorial Hospital, Memphis, TN

  • The Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • Mayo Clinic, Rochester, MN

  • Kaiser Permanente Northwest, Portland, OR

  • Center for Health Research, Kaiser Permanente Northwest, Portland, OR

  • Johns Hopkins Medicine, Baltimore, MD

  • Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA

  • University of California, San Francisco, San Francisco, CA

  • Johns Hopkins University School of Medicine, Baltimore, MD

Locations

  • United States

  • Canada

Companies

  • GenomeDx Biosciences

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved